This article is an erratum on:
Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research
Frontiers Production Office*An Erratum on
Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research
by Hernandez D, Danby RD and Querol S (2022). Front. Cell Dev. Biol. 10:979306. doi: 10.3389/fcell.2022.979306
Due to a publishing error the first two affiliations were listed incorrectly. Instead of “UCL Cancer Institute, Hampstead, United Kingdom”; and “University College London, London, United Kingdom,” they should be as follows:
“1 Anthony Nolan Research Institute, London, United Kingdom
2 UCL Cancer Institute, University College London, London, United Kingdom”
The publisher apologizes for this error and states that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: umbilical cord blood, cell and gene therapies, cord blood banking, iPSC (induced pluripotent stem cell), autism spectrum disorder ASD, cord blood transplantation (CBT)
Citation: Frontiers Production Office (2022) Erratum: Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research. Front. Cell Dev. Biol. 10:1066382. doi: 10.3389/fcell.2022.1066382
Received: 10 October 2022; Accepted: 10 October 2022;
Published: 24 October 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn